Skip to main content
. 2016 May 26;7(27):41885–41897. doi: 10.18632/oncotarget.9628

Table 1. Correlation of clinicopathological parameters and TACC3 expression.

Variable TACC3 expression
All cases Low expression High expression P valuea
Age (years)b 0.546
 < 53 63 31 (49.2%) 32 (50.8%)
 ≥ 53 98 53 (54.1%) 45 (45.9%)
Gender 0.989
 Female 71 37 (52.1%) 34 (47.9%)
 Male 90 47 (52.2%) 43 (47.8%)
Clinical Stage 0.045
 I+II 65 40 (61.5%) 25 (38.5%)
 III 69 35 (50.7%) 34 (49.3%)
 IV 27 9 (33.3%) 18 (66.7%)
T classification 0.029
 T1+T2 33 14 (42.4%) 19 (57.6%)
 T3 40 28 (70%) 12 (30%)
 T4 88 42 (47.7%) 46 (52.3%)
N classification 0.447
 N0 71 41 (57.7%) 30 (42.3%)
 N+
M classification 0.020
 M0 133 75 (56.4%) 58 (43.6%)
 M1 28 9 (32.1%) 19 (67.9%)
Pathologic Differentiation 0.549
 Well 3 1 (33.3%) 2 (66.7%)
 Moderately 150 80 (53.3%) 70 (46.7%)
 Poorly 8 3 (37.5%) 5 (62.5%)
Histological Types 0.865
 Non-mucinous adenocarcinoma 147 77 (52.3%) 70 (47.7%)
 mucinous adenocarcinoma 14 7 (50.0%) 7 (50.0%)
Location 0.267
 Colon 93 52 (55.9%) 41 (44.1%)
 Rectal 68 32 (47.1%) 36 (52.9%)
Vital status 0.058
 Alive 108 62 (57.4%) 46 (42.6%)
 Death 53 22 (41.5%) 31 (58.5%)
a

Chi-square test;

b

Median age.